Category: Side Effect: Blood-sugar Disorders (diabetes, hyperglycemia, hypoglycemia)
-
Prolia Increased Risk Of Hypocalcemia In Patients With Chronic Kidney Disease (CKD) Can Be 20-Times Higher Than Pills
Prolia "Black Box" Warning: Harm From Severe Hypocalcemia Ranges From Hospitalization For Life-threatening Events To Death (Posted by Tom Lamb at Drug Injury Watch) A January 2024 JAMA Original Investigation article, "Severe Hypocalcemia With Denosumab…
-
More Medical Evidence Indicates That Statin Drugs Like Lipitor Can Cause New-Onset Type 2 Diabetes
Benefit / Risk Assessment Of Statins Like Lipitor May Depend On Whether It Is A Medically Necessary Drug Therapy For The Particular Patient (Posted by Tom Lamb at DrugInjuryWatch.com)There is an ongoing debate in the…
-
Higher Doses Of Statin Drugs Such As Lipitor Associated With Higher Risk Of New-Onset Diabetes Mellitus (DM), Or Type-2 Diabetes
Recent Canadian Study Published In BMJ Medical Journal Suggests The Increased Risk Of Diabetes Seems To Be Highest In The First Four Months Of Statin Use (Posted by Tom Lamb at DrugInjuryWatch.com)According to the Parke-Davis,…
-
Pfizer’s Lipitor Statin Drug For Treatment Of High Cholesterol Linked To An Increased Risk Of Type-2 Diabetes In Some Older And Post-Menopausal Women
February 2012 FDA Drug Safety Warning About Lipitor Label Change Concerning New-Onset Diabetes Mellitus (DM) Has Gone Largely Unnoticed To Date (Posted by Tom Lamb at DrugInjuryWatch.com)Statins are a class of prescription drugs used…
-
Levaquin Has Been Associated With Dysglycemia Events Such As Hyperglycemia And Hypoglycemia
North Carolina Case Report: Man With Diabetes Develops Low Blood Sugar After Using Levaquin Together With Glucotrol (Posted by Tom Lamb at DrugInjuryWatch.com) Three years ago to the day we posted an article, back in…
-
FDA’s Delayed Announcement About Possible Insulin Overdoses Due To Recalled Syringes
Tyco Healthcare Group LP (Covidien) Recall Of ReliOn Disposable Syringes Was First Announced October 9, 2008; FDA Press Release About This Syringe Recall Is Dated November 5, 2008 (Posted by Tom Lamb at DrugInjuryWatch.com)…
-
Tequin Revisited: Health Canada And The FDA Failed To Take Action, At Our Expense
Bristol-Myers Squibb Was Allowed To Withdraw Their Unsafe Drug For "Economic Reasons", And Only After Selling Off Its Inventory (Posted by Tom Lamb at DrugInjuryWatch.com) An article by Joel Lexchin, MSc MD, "Information about…
-
FDA Letter Concerning Sybmyax May Result In More Zyprexa Lawsuits For Lilly
According To Bloomberg Report, FDA Wants Information About Weight Gain And High Levels Of Blood Sugar Added To Zyprexa Label (Posted by Tom Lamb at DrugInjuryWatch.com) On June 29, 2007 Bloomberg published an article…
-
900 More Zyprexa Lawsuits Settled By Eli Lilly And Co.
Drug Maker Still Faces Product Liability Cases Involving 750 Zyprexa Patients (Posted by Tom Lamb at DrugInjuryWatch.com) A June 12, 2007 Associated Press (AP) article reports that the Eli Lilly and Co. has settled…
-
Levaquin Associated With Blood Sugar Problems And Liver Disorders
January 2007 Article Sets Forth Reports Made To Health Canada In Past Ten Years (Posted by Tom Lamb at DrugInjuryWatch.com) The January 2, 2007 edition of the Canadian Adverse Reaction Newsletter (Volume 17, Issue…